ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ATHA Athira Pharma Inc

1.922
0.002 (0.10%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Athira Pharma Inc ATHA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.002 0.10% 1.922 13:00:06
개장가 저가 고가 종가 전일 종가
1.92 1.91 2.01 1.922 1.92
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/04/202420:00GLOBEAthira Pharma Appoints Javier San Martin, M.D., as Chief..
11/04/202420:00GLOBEAthira Pharma Announces Publication of Preclinical Data..
03/04/202420:00GLOBEAthira Pharma Announces Upcoming Poster Presentation at..
08/03/202421:00GLOBEAthira Pharma Presents Clinical and Preclinical Data..
23/02/202406:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/02/202406:10EDGAR2Form 8-K - Current report
23/02/202406:05GLOBEAthira Pharma Reports Full Year 2023 Financial Results and..
17/02/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:40EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
09/02/202406:02GLOBEAthira Pharma Announces Publication in Frontiers in..
09/01/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202421:11EDGAR2Form 8-K - Current report
08/01/202421:00GLOBEAthira Pharma Provides 2024 Clinical Pipeline Outlook and..
03/01/202421:00GLOBEAthira Pharma Completes Enrollment of Phase 2/3 LIFT-AD..
12/12/202321:00GLOBEAthira Pharma Announces Encouraging Results from SHAPE Phase..
29/11/202321:00GLOBEAthira Pharma to Participate in Sidoti December Small Cap..
28/11/202321:00GLOBEAthira Pharma Announces Upcoming Presentation at Motor..
15/11/202322:15GLOBEAthira Pharma Presents Preclinical Data Highlighting..
10/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:10EDGAR2Form 8-K - Current report
10/11/202306:05GLOBEAthira Pharma Reports Third Quarter 2023 Financial Results..
08/11/202321:00GLOBEAthira Pharma to Participate in Jefferies London Healthcare..
06/10/202305:30GLOBEAthira Pharma Presents Preclinical Data Further Supporting..
28/09/202320:00GLOBEAthira Pharma to Participate in Upcoming October Conferences
19/09/202320:00GLOBEAthira Pharma to Participate in the 2023 Cantor Fitzgerald..
11/08/202305:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:10EDGAR2Form 8-K - Current report
11/08/202305:05GLOBEAthira Pharma Reports Second Quarter 2023 Financial Results..
17/07/202320:00GLOBEAthira Pharma Presents Phase 2 Clinical Data Correlating..
06/07/202320:00GLOBEAthira Pharma Announces Upcoming Presentations at the..
31/05/202320:00GLOBEAthira Pharma to Participate in Upcoming June Conferences
22/05/202320:00GLOBEAthira Pharma Appoints Andrew Gengos as Chief Financial..
12/05/202305:05GLOBEAthira Pharma Reports First Quarter 2023 Financial Results..
08/05/202320:00GLOBEAthira Pharma to Participate in Upcoming May Investor..

최근 히스토리

Delayed Upgrade Clock